ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CYCCP Cyclacel Pharmaceuticals Inc

6.99
0.00 (0.00%)
After Hours
Last Updated: 07:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cyclacel Pharmaceuticals Inc CYCCP NASDAQ Preference Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 6.99 07:00:00
Open Price Low Price High Price Close Price Previous Close
6.89 6.89 6.89 6.99 6.99
more quote information »

Recent News

Date Time Source Heading
17/5/202423:56EDGAR2Form D - Notice of Exempt Offering of Securities
15/5/202407:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202406:05EDGAR2Form 8-K - Current report
15/5/202406:05GLOBECyclacel Pharmaceuticals Reports First Quarter Financial..
14/5/202406:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/5/202423:15GLOBECyclacel Pharmaceuticals to Release First Quarter 2024..
08/5/202411:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/5/202411:52EDGAR2Form DEF 14A - Other definitive proxy statements
07/5/202407:26EDGAR2Form S-1 - General form for registration of securities under..
03/5/202406:30GLOBECyclacel Pharmaceuticals Announces Closing of $8.0 Million..
01/5/202403:51APS$8 Million Private Placement Announcement Sends Biotech..
30/4/202421:00GLOBECyclacel Pharmaceuticals Announces $8.0 Million Private..
02/4/202400:15GLOBECyclacel Pharmaceuticals to Present New Clinical Data at..
20/3/202407:05GLOBECyclacel Pharmaceuticals Reports Fourth Quarter and Full..
14/3/202407:05GLOBECyclacel Pharmaceuticals to Release Fourth Quarter and Full..
08/3/202401:15GLOBECyclacel Pharmaceuticals Announces Preclinical..
07/3/202401:15GLOBECyclacel Pharmaceuticals Announces Receipt of $2.9 Million..
21/2/202401:15GLOBECyclacel Pharmaceuticals to Participate in 2024 BIO CEO &..
15/2/202408:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202408:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/2/202402:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202407:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202409:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202408:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202401:15EDGAR2Form 8-K - Current report
31/1/202401:15GLOBECyclacel Pharmaceuticals Announces the Appointment of Brian..
20/1/202408:58EDGAR2Form S-1 - General form for registration of securities under..
13/1/202408:05EDGAR2Form 8-K - Current report
11/1/202405:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/1/202408:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/1/202408:05EDGAR2Form 8-K - Current report
27/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202301:29EDGAR2Form 8-K - Current report
27/12/202301:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/12/202301:00GLOBECyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data..
13/12/202308:06EDGAR2Form 8-K - Current report
13/12/202308:05GLOBECyclacel Pharmaceuticals Announces Reverse Stock Split
01/12/202301:15GLOBECyclacel Regains Compliance With Nasdaq Listing Rule..
29/11/202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/11/202313:20EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
29/11/202309:15GLOBECyclacel Receives Notification of Deficiency From Nasdaq..
29/11/202308:59EDGAR2Form 8-K - Current report
16/11/202309:04EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
16/11/202309:03EDGAR2Form 8-K - Current report
14/11/202308:06EDGAR2Form 8-K - Current report
08/11/202308:10EDGAR2Form 8-K - Current report
08/11/202301:15GLOBECyclacel Pharmaceuticals to Release Third Quarter 2023..
03/11/202307:30EDGAR2Form PRE 14A - Other preliminary proxy statements
09/9/202306:10EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock